There is little information about analgesia use or pain experienced in children after neurosurgery. The aims of this study were to assess the degree of pain experienced by children after neurosurgery and the analgesic regimens used, and to identify factors associated with significant pain. Data for 52 children who underwent craniotomy were collected contemporaneously over 72 hours. Data included demographics, intraoperative surgical and anaesthetic details, postoperative medications and postoperative pain scores as routinely collected by nursing staff. Pain was also assessed by an independent observer (auditor) using an age and developmentally appropriate tool, on a scale from zero to 10.
Analgesia requirement after neurosurgery is a controversial topic. It is established in the adult neurosurgical patient population that significant pain is not uncommon and strong analgesics are frequently required [1] [2] [3] [4] [5] . It is acknowledged that poorly treated pain may lead to intracranial hypertension, but the optimal form of analgesic therapy is still unclear. While opioids provide effective pain relief, some neurosurgeons continue to be concerned that sedation with opioid analgesia may mask developing neuropathology. In children, there are very few data describing pain or analgesic needs after neurosurgery. This study aimed to determine the degree of pain and form of analgesic use in paediatric neurosurgical patients who underwent a craniotomy at a tertiary paediatric centre.
A secondary aim was to determine factors associated with greater analgesic requirement and greater pain.
MATERIALS AND METHODS
After institutional approval, a six-month prospective audit of paediatric patients who underwent elective or emergency craniotomy at the Royal Children's Hospital in Melbourne was performed. Patients were all extubated directly following surgery and were followed postoperatively for 72 hours.
Data collected included patient demographics, surgical and anaesthetic details, and details of postoperative analgesia. These were obtained from the medical history, patient's operation report and anaesthetic charts, post-anaesthetic care unit (PACU) notes, medication charts, patients' and/or parents' report, ward observation charts and postoperative nursing notes.
Pain scores were obtained from nursing documentation and twice daily by an independent observer (auditor). Both nurses and auditor (JT) recorded pain scores via observation or self-report (according to the patient's age and expressive and receptive ability). The auditor pain score was the pain at rest at the time the auditor reviewed the child. The three tools used are validated and used by the institution's pain service: the observational pain measurement tool Faces, Legs, Activity, Cry and Consolability Scale for those under five years, self-report via the Wong-Baker Faces Scale for those aged five to seven years and self-report using the Numeric Rating Scale for older patients. In the event that patients were cognitively impaired, pain scores were obtained from the parents as a proxy, using the Numeric Rating Scale. The number of pain scores documented by nurses per day was also noted. At each visit, the type of pain therapy prescribed, route, dosage and frequency of administration were also recorded, including the total duration of any parenteral opioid (via patient-controlled analgesic device [PCA] or infusion).
These data were entered into a database using EpiData 3.1 (The Epidata Association, Denmark, 2003-4) . Data management and analysis were performed using STATA Version 10.0 (Stata Statistical Software, StataCorp LP, Texas, USA). Descriptive statistics were used to summarise continuous data. Normally distributed data were described using mean and standard deviation while skewed data were described using median and interquartile range (IQR). Categorical data were summarised as frequency and percentages.
Parenteral morphine use >24 hours and a pain score ≥3 as recorded by the auditor were defined as two different measures of clinically significant pain for further analysis. Each of these outcomes was analysed separately. A univariate analysis was performed seeking evidence of association with these two outcomes using Pearson's chi-square test for categorical variables and Mann-Whitney U test for continuous non-symmetric variables (respectively), and a multiple logistic regression was performed.
RESULTS
Fifty-two patients presented for craniotomies at Royal Children's Hospital from September 2007 to April 2008. Their demographic details and type of craniotomy are listed in Table 1 . Nine children had cognitive impairment with a median age of 7.2 years (range 2.0 to 15.9). Most children (79%) received pre-incisional scalp infiltration with bupivacaine and adrenaline. Only a small number (4%) received scalp nerve blocks prior to incision and no child received scalp blocks at the end of the procedure. Remifentanil was used intraoperatively for 69% of children. Morphine was administered intraoperatively as a loading dose in 67% of children, and given most commonly in those who received a posterior fossa approach (82%). Twenty-two children required rescue analgesia in the immediate postoperative period. Parenteral morphine was given in 20 cases and paracetamol in two cases. Figure 1 represents the postoperative analgesia received on the ward. Some children received codeine or oxycodone after parenteral morphine was ceased (i.e. as step-down). The mean duration of parenteral morphine use was 33.9 hours delivered via infusion and 26.6 hours by PCA. Patients who underwent posterior fossa craniotomy had a longer mean duration of postoperative parenteral morphine use (43.2 hours) compared to patients who underwent craniotomy at other sites (27.8 hours) (P=0.03). No episode of respiratory depression was recorded.
Postoperative pain

Pain scores
The nurses and auditor generally found low pain scores over the 72 postoperative hours (median 0.7 [IQR 0.3 to 1.4] and 1.3 [IQR 0.3 to 3.2] respectively). The median of nursing-documented pain scores decreased over 72 hours, but there was no evidence for a change in the auditor's documented median pain scores over this time period (Figures 2 and 3) . The auditor documented pain scores twice daily for all patients (n=104). However, the nursing documentation reduced in frequency over the three postoperative days, from 7 (IQR 2 to 11) on day one Step down: Despite the low median pain scores documented, 40.4% of patients required parenteral morphine for >24 hours and 42.3% of children had at least one episode of pain scoring ≥3 (as documented by the auditor).
Morphine use changed with age. For PCA (all children older than seven years), the mean dose of morphine per kg over the first 72 hours was 1.02 mg/kg (n=17). For intravenous morphine infusion the mean dose of morphine per kg over the first 72 hours was 0.41 mg/kg for children less than five years (n=10), 0.27 mg/kg for children between five and seven years (n=3) and 0.15 mg/kg for children over seven years (n=6). Five of the six older children having morphine infusions were cognitively impaired.
Factors associated with prolonged use of morphine and episodes of greater pain
In the univariate analysis (Table 2) , there was an association between morphine given in PACU and parenteral morphine use of >24 hours (P=0.02) and a pain score of <3 during the postoperative period (P=0.046). Overall, there was strong association between older age and pain scores of ≥3 as collected by the auditor (P=0.0002). There was no association between intraoperative technique or site of surgery and parenteral morphine use of >24 hours or pain score <3.
In the multivariate regression, duration of procedure remained strongly associated with parenteral morphine use of >24 hours (odds ratio 1.4, P=0.02). Other factors included in the regression model (age, intraoperative morphine use, morphine administered at PACU) showed no association with duration of analgesia use. After adjustment for factors such as duration of procedure and administration of morphine in PACU, having a pain score of ≥3 was associated with older age (odds ratio 1.2, P=0.002). 
DISCUSSION
In the adult neurosurgical literature, it has been reported that 41 to 76% of craniotomy patients experienced moderate to severe pain within the first 48 postoperative hours 1,3-5 . However, in our audit, children undergoing craniotomy generally experienced little or no pain within the first 72 postoperative hours. This is in the context of postoperative use of multimodal analgesia commonly incorporating parenteral morphine.
Procedures of a longer duration were associated with a longer period of postoperative parenteral morphine use. As a possible explanation, longer surgical duration is usually indicative of the requirement for greater surgical dissection and/or technical challenge and translates to the patient having a longer period of surgical stimulus and thus wind-up of pain pathways, even within groups where the primary skin and bone incision is the same. Older age was associated with reporting pain scores ≥3 (i.e. by adolescent patients). This may relate to a developmental phenomenon where the older subject perceives greater degrees of pain or has better understanding of the concept of self-reporting and use of the Numeric Rating Scale tool and broader life and/or previous pain experiences. Interestingly, of the older patients, more were using a PCA and thus able to self-titrate analgesia. The duration of morphine use was significantly shorter when using PCA than for younger patients receiving a nurse-controlled morphine infusion, but the total dose of morphine used per kg was substantially higher in older children using PCA compared to younger children on infusions. When infusions were used, the total dose per kg was less in older children, many of whom were cognitively impaired.
Regarding procedure subtypes, adult neurosurgical patients who have received posterior fossa craniotomy have reported greater levels of postoperative pain than those who have had procedures performed on other sites 1, 3, 5 . The current paediatric audit revealed that children who underwent posterior fossa craniotomy had lower documented pain scores when compared to those who received craniotomy procedures at other sites. Notably, these patients also used parenteral opioid for almost an extra day postoperatively when compared to the other surgical categories.
With respect to the type of analgesia used in this group of patients, the frequent use of parenteral morphine has already been emphasised. Codeine has been traditionally favoured for post-neurosurgical pain relief, due to the false belief that its side-effect profile differs from morphine (which is codeine's active metabolite). An additional issue is the variability in pharmacokinetics with a significant proportion of the population being poor or nonmetabolisers and the developmental aspect suggesting that children under 12 years are more frequently non-metabolisers 6 . For these reasons, our institution's pain service would like to see the use of codeine phased out. Pleasingly, less than one-fifth of the children received codeine as the sole opioid and a further one-fifth received it as a step-down analgesic. In contrast, a relatively recent 2005 survey reports the wide use of codeine in adult neurosurgery where 78% of 23 British centres report use of oral or intramuscular codeine phosphate 7 . This is in spite of a 1996 UK comparative study concluding that intramuscular codeine is inadequate in postneurosurgical pain relief 8 , and a nursing review article in 1998 that recommended codeine should not be given intramuscularly for post-neurosurgical patients 9 .
There are several limitations to the current study. Pain is widely recognised as a subjective experience 10 . To achieve optimal postoperative analgesic effect, patients need to self-report their pain experience on a regular basis 11, 12 . However, the suggested frequency of nursing pain score documentation for patients on parenteral or oral analgesia (one and four-hourly respectively as per the institution's pain management guidelines) was not achieved by the ward staff 13 . Low levels of documentation may influence the interpretation of the postoperative pain experience of these patients. The additional pain scoring by the auditor provides only a limited window of information, as this scoring was performed twice daily. In addition, although observational pain scores are validated in pre-verbal and cognitively impaired children, they may not be directly comparable with self-reporting pain scales and hence pooling of such scores into a single analysis may lead to a confounding influence of age.
Pain may also be under-reported, as it is well recognised that patients vary in their pain thresholds and coping strategies. They may not readily verbalise discomfort and remain quiet instead when in pain 14 , which might lead to underscoring using either a self-report or observational tool. In this audit, the variability in the population and intraoperative techniques for neurosurgical anaesthesia provide some opportunity to explore associations between practice and pain. However, the small numbers limit the power of this aspect of the analysis.
Despite previous suggestions of the need for a post-neurosurgery analgesic regimen for paediatric patients 14, 15 , neither an audit nor a comparison of different regimens has previously been published. In this audit, we found that relatively little pain was reported in the paediatric neurosurgical population in the setting of substantial multimodal postoperative analgesic use. It was also found that a small number of children still experienced significant pain -particularly older children who had longer procedures. This suggests there is still room for further work on optimising analgesia in children after neurosurgery.
